Advocacy

CHADD is part of a social movement that seeks to shape the conversation on how society treats, accommodates, and views people affected by ADHD. Our movement is made up of countless people affected by ADHD, their families, teachers, friends, and leaders in the fields of ADHD research, education, and mental health. We realize the most effective way to accomplish our goals is through sustained and strategic outreach to policymakers on the state and federal levels.

We are making a difference for families and adults affected ADHD. And we need your help! We want you to be equipped with information to make a difference in your own life, whether that means dealing with issues in the classroom, the boardroom, or your living room.

CALLS TO ACTION

Contact Your Senators to Request an Increase in Funding for ADHD for the National Center on Birth Defects ad Developmental Disabilities

We urge you to contact your senators to ask them to support the at least 17 million individuals in the United States with ADHD, along with their families, by increasing funding for ADHD research and education.

CURRENT ISSUES

A Way You Can Address the Medication Shortage

June 28, 2023
Parent with child talking to a pharmacist about ADHD meds / medication and substance use concerns.

We have heard the frustrations many members of the ADHD community are experiencing when they go to refill their ADHD medications, the disappointment and worry when the pharmacy is unable to fill a prescription because of the ongoing shortage. CHADD’s public policy committee is pursuing all appropriate channels to bring this to the attention of…

Protecting Youth Mental Health: The US Surgeon General’s Advisory

February 15, 2022

The challenges today’s generation of young people face are unprecedented and uniquely hard to navigate. And the effect these challenges have had on their mental health is devastating. Recent national surveys of young people have shown alarming increases in the prevalence of certain mental health challenges. We know that mental health is shaped by many…

Developing Diagnosis and Treatment of Adult ADHD Guidelines

January 15, 2022

In 2022, CHADD received funds from a generous donor to sponsor and support the development of national guidelines in the U.S. for the diagnosis and treatment of adult ADHD. This milestone has been achieved due to the sustained efforts of our Public Policy Committee and builds on the committee’s published recommendations emerging from a national…

CHADD’s Statement at the Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder

October 8, 2020

Posted October 8, 2020 Presentation to the Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the US Food and Drug Administration Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder Presented by Robert Cattoi, CHADD Chief Executive Officer Children and Adults with Attention-Deficit/Hyperactivity Disorder…

UPDATE: CARES Act And Protecting Educational Rights of Students With ADHD

April 29, 2020

CHADD is pleased to report that Secretary of Education Betsy DeVos will not seek changes to the central tenets of the Individuals with Disabilities Education Act (IDEA) in response to the novel coronavirus pandemic. In her report, the Secretary is “not requesting waiver authority for any of the core tenets of the IDEA or Section…

CARES Act And Protecting Educational Rights of Students With ADHD

April 21, 2020

Read the update to this post. Dear Parents, The Coronavirus Aid, Relief, and Economic Security (CARES) Act, PL 116-136, directs Secretary of Education Betsy DeVos to report back to Congress no later than April 26, 2020, on any waivers needed under the Individuals with Disabilities Education Act (IDEA) and the Rehabilitation Act of 1973 (Section…

ADVOCACY PARTNERS

FEDERAL GOVERNMENT

ADULT ADHD GUIDELINES DEVELOPMENT

The recent surge in adults seeking care for ADHD, coupled with a steady increase in ADHD medication prescriptions, has underscored the pressing need for diagnostic and treatment guidelines.

To address this issue, CHADD has partnered with the American Professional Society for ADHD and Related Disorders (APSARD) to develop and distribute guidelines in 2025. APSARD is leading the charge in developing the guidelines for review. CHADD is taking the lead in developing resources and toolkits for healthcare providers across the United States to implement the new diagnostic and treatment guidelines.

WEBINARS

The Importance of Adult ADHD Guidelines

Download Slides

Dr. Peter Jensen, founder of The REACH Institute, is the director of a coalition of organizations developing adult ADHD diagnosis and treatment guidelines for use in the United States, a joint effort of CHADD and APSARD.

For more information on the development of adult guidelines, read The Quest for Clinical Practice Guidelines for ADHD in Adults.

Previous Lunch and Learn Webinars

What Is ADHD? How It Affects Children and Adults

Max Wiznitzer, MD, discusses the medical science of ADHD and how it is expressed in children and adults. ADHD impairs many aspects of life, and it is important that the public and policymakers have an understanding of the disorder when addressing laws and policies regarding ADHD and its treatment.

RESOURCES

WHITE PAPER

The Adverse Health Outcomes, Economic Burden, and Public Health Implications of Unmanaged Attention Deficit Hyperactivity Disorder (ADHD): A Call to Action to Improve the Quality of Life and Life Expectancy of People with ADHD

 

Proceedings of the ADHD Public Health Summit
Washington, DC
October 7, 2019

 

Presented by Children and Adults with Attention-Deficit/ Hyperactivity Disorder (CHADD)

TOOLKITS